Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06143670 · ClinicalTrials.gov registry record · NA
A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks
A NA study, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
NCT06143670 is a NA study that has completed, run by HALEON. The registered enrollment target is 159 participants.
The verdict
NCT06143670, a NA study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to investigate the efficacy of a dentifrice containing 0.454 percent (%) weight by weight (w/w) stannous fluoride (SnF2), on gingivitis treatment and plaque reduction, compared to a regular fluoride dentifrice after 12 weeks twice daily brushing in a population of clinically diagnosed gingivitis without undergoing dental prophylaxis.
Interventions
- DRUG Stannous fluoride toothpaste
- DRUG Sodium fluoride toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2024-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06143670
The ClinicalTrials.gov registry entry for NCT06143670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stannous fluoride toothpaste is the first listed.
NCT06143670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06143670 about?
NCT06143670 is a clinical study titled "A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks". The purpose of this clinical study is to investigate the efficacy of a dentifrice containing 0.454 percent (%) weight by weight (w/w) stannous fluoride (SnF2), on gingivitis treatment and plaque reduction, compared to a regular fluoride dentifrice after 12 weeks twice daily brushing in a population ...
What is the current status of trial NCT06143670?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2023-11-29. Estimated completion is 2024-03-12.
What interventions are being tested in trial NCT06143670?
The interventions under investigation include: Stannous fluoride toothpaste (DRUG), Sodium fluoride toothpaste (DRUG).
Who is sponsoring clinical trial NCT06143670?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.